UFC fighter Lyman Good claims his multi-vitamin was adulterated with an illegal steroid, causing him to fail a drug test, but according to a judge, he failed to make his case.
A contract manufacturer has received a warning letter for manufacturing products containing the stimulant DMHA, which was the subject of a concerted FDA enforcement action in 2019.
Ahead of the UK Food Standards Agency’s 31 March 2021 deadline for CBD products to have a validated novel foods application, the Association for the Cannabinoid Industry (ACI), which works to create a safe, legal and well-regulated CBD market in the UK,...
In light of the ongoing uncertainty around the COVID-19 public health crisis, the IPA World Congress + Probiota Americas 2020 has been canceled, but will return June 16-18, 2021 in Washington, D.C.
With the regulatory path forward for hemp-derived CBD in foods and supplements no clearer a year after the FDA’s May 2019 public meeting, trade association The Council for Responsible Nutrition (CRN) has filed a citizen’s petition urging the FDA to regulate...
A US Food and Drug Administration study reveals that a number of the products it tested labeled as ‘bitter orange’ did not meet label claim for synephrine content and more than 10% contained undeclared synthetic ingredients.
A group of hemp/CBD purveyors have teamed up with a clinical research firm to conduct a large scale study to provide the safety data that the US Food and Drug Administration says it lacks.
As Americans begin to emerge from quarantine and many cities begin the process of getting back to ‘normal,’ the FTC continues to keep an eye on companies making unsupported coronavirus claims.
The prevalence of virus-treatment claims in the marketplace has made for both heightened enforcement from federal regulators and calls for even more action from an advocacy group regarding products sold on Amazon.
The FDA says it has made “substantial progress” in forging a regulatory path for ingestible CBD products, but has given no indication of when it might provide food and supplement makers with more clarity.
A recent warning letter to a Colorado dietary supplement formulator has put front and center FDA’s determination that CBD should not be a constituent of dietary supplements.
The Natural Products Association (NPA) is calling for the US Food and Drug Administration to use import alerts to stop nutritional supplements that fail to comply with New Dietary Ingredient (NDI) regulations.
A judge has approved a permanent injunction order against the principals of a dietary supplement company who allegedly repeatedly ignored FDA warnings and inspection findings on illegal disease claims and other violations.
The Federal Trade Commission continues to be vigilant in policing health-related claims, after announcing over 22,580 refund checks would be mailed this week to consumers nationwide.
